Cabazitaxel (Jevtana), a chemotherapy drug used with prednisone for prostate cancer. ... It is the first treatment for advanced, hormone-refractory prostate cancer that has worsened during or after treatment with docetaxel.
African-American men have a much higher rate of aggressive prostate cancer and men in high risk groups may get higher benefit from these tests. ... The American Cancer Society estimates that 241,740 men will be diagnosed with prostate cancer this year,
Preventive Services Task Force finding that prostate-specific antigen (PSA) screening for prostate cancer does more harm than good, the most frequent response I hear from physicians who continue to defend ... That's pretty much what we do by deploying
Sipuleucel-T (Provenge), autologous cellular immunotherapy approved to treat asymptomatic or minimally symptomatic prostate cancer that has spread to other parts of the body and is resistant to standard hormone treatment. ... cancer. Most of the studies
and finally, (5) the nature of the nature/nurture debate and its pertinence to prostate cancer screening. ... 2) Prostate cancer is unpredictable. Most men who die after age 80 die with it, but not of it.
Given that many patients with prostate cancer have normal PSAs and lots of patients with high PSAs don't have prostate cancer, it doesn't seem semantically correct to call it ... prostate cancer screening".) Surprise!
because of shortages of propofol injection. The FDA is currently studying whether Stalevo, a Parkinson's disease medication, is associated with an increased risk for developing prostate cancer. ... Researchers unexpectedly found that more patients taking
Researchers conducted a survey by mail among 1,600 Medicare beneficiaries 66 years or who had undergone surgery for prostate cancer or elective coronary artery stenting in 2008. ... The goal was to compare discussions about prostate cancer and stents,
For prostate cancer, the SEER data show a median age of 67 years at diagnosis, and for death from prostate cancer, 80 years. ... So the potential number of life-years saved by early detection and intervention is, on average, greater for breast cancer
It also dissolves easily in a small volume of water. Tbo-filgrastim, a biologic drug to reduce severe neutropenia in patients receiving cancer chemotherapy. ... Enzalutamide (Xtandi) to treat metastatic castration-resistant prostate cancer that has